Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
228.49 +0.25 / +0.11%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
227.12 -1.37 / -0.60%
Volume: 800.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 2
Quarter 3
Quarter 4
Quarter 1
Operating ActivitiesNet Income / Starting Line122.6M276.7M508.1M74.5M
Total Other Cash Flow34.6M-105.7M245.5M156.4M
Funds From Operations548.0M683.5M1.1B700.4M
Funds From/For Other Operating Expenses167.1M66.2M374.3M209.3M
Net Cash Flow - Operating Activities380.9M617.4M749.1M491.1M
InvestingIncrease In Investments-76.3M249.7K-67.8M0.00
Decrease In Investments0.000.00125.6M17.7M
Capital Expenditures-114.5M-39.1M-71.9M-65.8M
Fixed Asset Disposal1.4M1.5B-32.1M--
Net Assets From Acquisitions -70.1M-607.0M-88.8M-795.0M
Other Investing - Uses0.000.000.00-10.3B
Other Investing - Sources------500.0K
Net Cash Flow Investing-270.1M760.3M-203.0M-11.2B
FinancingShort Term Borrowings-3.3M122.6K-2.0M0.00
Long Term Borrowings51.4M544.8M587.2M12.0B
Long Term Debt Reduction-123.5M-1.6B-1.6B-1.1B
Net Proceeds Stock Sale3.6M3.8M5.8M1.4B
Common Preferred Redeemed0.
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing6.8K15.9M-511.2K18.8M
Other Uses - Financing86.4M16.5M10.4M28.2M
Net Cash Flow - Financing-158.2M-1.1B-1.0B12.3B
Exchange RateEffect of Exchange Rate on Cash1.9M-15.3M-13.3M-15.1M
Net Change In Cash-47.4M293.8M-465.8M1.6B

To view my watchlist

Not a member yet?

Sign up now for a free account